ENTITY

Shanghai Henlius Biotech (2696 HK)

Analysis

Health Care • China

Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.

Refresh

Focused

No publications yet

Add Shanghai Henlius Biotech to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00